VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM), a late-stage oncology company, today announced that it intends to offer and sell common stock and six month warrants in a “best efforts” underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed.
Help employers find you! Check out all the jobs and post your resume.
